Cargando…

The impact of renal protection clinics on prescription of and adherence to cardioprotective drug therapy in chronic kidney disease patients

Background: The aim of this study was to assess the impact of follow-up in renal protection clinics on the prescription of and adherence to cardioprotective drugs in patients with chronic kidney disease (CKD). Methods: We studied stage 4 and 5 CKD patients who initiated follow-up in three renal prot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lepeytre, Fanny, Cardinal, Héloise, Fradette, Lorraine, Verhave, Jacobien, Dorais, Marc, LeLorier, Jacques, Pichette, Vincent, Madore, François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Cardiovascular Disease and CKD
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466117/ https://www.ncbi.nlm.nih.gov/pubmed/28616215 http://dx.doi.org/10.1093/ckj/sfw144

Ejemplares similares

Effect of cinacalcet availability and formulary listing on parathyroidectomy rate trends
por: Lafrance, Jean-Philippe, et al.
Publicado: (2013)

A scheme based on ICD-10 diagnoses and drug prescriptions to stage chronic kidney disease severity in healthcare administrative records
por: Friberg, Leif, et al.
Publicado: (2018)

Non-steroidal anti-inflammatory drugs in chronic kidney disease: a systematic review of prescription practices and use in primary care
por: Lefebvre, Claire, et al.
Publicado: (2019)

Approach to atherosclerotic renovascular disease: 2016
por: Daloul, Reem, et al.
Publicado: (2016)

Cardiovascular-renal complications and the possible role of plasminogen activator inhibitor: a review
por: D'Elia, John A., et al.
Publicado: (2016)

Acceptability of a multilevel intervention to improve blood pressure control among patients with chronic kidney disease in a public health care delivery system
por: Strait, Adrienne, et al.
Publicado: (2018)

Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease
por: Gillis, Keith, et al.
Publicado: (2018)

Ascorbic acid: a promising agent in chronic kidney disease?
por: Karahan, Salih, et al.
Publicado: (2018)

Prevalence of chronic kidney disease and association with cardiovascular risk factors among teachers in Cape Town, South Africa
por: Adeniyi, Aderemi B., et al.
Publicado: (2017)

Epidemiology of chronic kidney disease: think (at least) twice!
por: Delanaye, Pierre, et al.
Publicado: (2017)

Warfarin-related nephropathy induced by three different vitamin K antagonists: analysis of 13 biopsy-proven cases
por: Golbin, Léonard, et al.
Publicado: (2017)

Renal artery intervention utilizing carbon dioxide angiography
por: Sag, Alan A, et al.
Publicado: (2017)

Symptom burden in patients with chronic kidney disease not requiring renal replacement therapy
por: Brown, Stephanie A, et al.
Publicado: (2017)

Renal denervation using carbon dioxide renal angiography in patients with uncontrolled hypertension and moderate to severe chronic kidney disease
por: Hameed, Mohammed Awais, et al.
Publicado: (2017)

Patterns of progression of chronic kidney disease at later stages
por: Caravaca-Fontán, Fernando, et al.
Publicado: (2018)

The relationship between kidney function and quality of life among community-dwelling adults varies by age and filtration marker
por: Canney, Mark, et al.
Publicado: (2018)

Frailty and chronic kidney disease: current evidence and continuing uncertainties
por: Nixon, Andrew C, et al.
Publicado: (2018)

Incorporating patient-reported symptom assessments into routine care for people with chronic kidney disease
por: van der Veer, Sabine N, et al.
Publicado: (2017)

The metabolomic quest for a biomarker in chronic kidney disease
por: Davies, Robert
Publicado: (2018)

The European Renal Association – European Dialysis and Transplant Association Registry Annual Report 2014: a summary
por: Pippias, Maria, et al.
Publicado: (2017)

Current trends in European renal epidemiology
por: Heaf, James
Publicado: (2017)

Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease
por: Vega, Almudena, et al.
Publicado: (2017)

Quality of life with conservative care compared with assisted peritoneal dialysis and haemodialysis
por: Iyasere, Osasuyi, et al.
Publicado: (2018)

Clarifying the concept of chronic kidney disease for non-nephrologists
por: Perez-Gomez, Maria Vanessa, et al.
Publicado: (2019)

Impact of a phone app on nephrology referral
por: Oliva-Damaso, Nestor, et al.
Publicado: (2018)

Chronic kidney disease and urological disorders: systematic use of uroflowmetry in nephropathic patients
por: Lai, Silvia, et al.
Publicado: (2018)

Anticoagulant-related nephropathy: systematic review and meta-analysis
por: de Aquino Moura, Karolinny Borinelli, et al.
Publicado: (2019)

Single-dose sodium polystyrene sulfonate for hyperkalemia in chronic kidney disease or end-stage renal disease
por: Hunt, Taylor V, et al.
Publicado: (2018)

Obesity and chronic kidney disease progression—the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1
por: Barbieri, Diego, et al.
Publicado: (2018)

Is polypharmacy an increasing burden in chronic kidney disease? The German experience
por: Parker, Kathrine, et al.
Publicado: (2019)

Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study
por: Schmidt, Insa M, et al.
Publicado: (2019)

Circulating active von Willebrand factor levels are increased in chronic kidney disease and end-stage renal disease
por: van der Vorm, Lisa N, et al.
Publicado: (2019)

Adherence to medication in patients with chronic kidney disease: a systematic review of qualitative research
por: Mechta Nielsen, Trine, et al.
Publicado: (2018)

Are oxyphil cells responsible for the ineffectiveness of cinacalcet hydrochloride in haemodialysis patients?
por: Rottembourg, Jacques, et al.
Publicado: (2018)

Strategies to increase living kidney donation: a retrospective cohort study
por: Cardinal, Héloïse, et al.
Publicado: (2015)

Factors associated with parathyroid hormone control in haemodialysis patients with secondary hyperparathyroidism treated with cinacalcet in real-world clinical practice: Mimosa study
por: Rottembourg, Jacques, et al.
Publicado: (2019)

Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease
por: Ureña-Torres, Pablo A, et al.
Publicado: (2018)

Pharmacologically pertinent period of effect (PPPE)
por: Suissa, Melanie, et al.
Publicado: (2019)

Multimodal treatment of calcific uraemic arteriolopathy (calciphylaxis): a case series
por: Russo, Domenico, et al.
Publicado: (2016)

Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients
por: Cianciolo, Giuseppe, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3t2n7rcmemkf8p5d5l9lcbahn8